Everest Organics Limited (EVERESTO.BO)
INR 257.5
(4.99%)
INR 257.5
(4.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.39 Million INR | 176.4% |
| 2022 | -1.82 Million INR | -115.93% |
| 2021 | 11.43 Million INR | -91.66% |
| 2020 | 137.15 Million INR | 25.86% |
| 2019 | 108.96 Million INR | 45.12% |
| 2018 | 75.08 Million INR | 338.09% |
| 2017 | 17.13 Million INR | 26.78% |
| 2016 | 13.51 Million INR | 649.09% |
| 2015 | 1.8 Million INR | -89.08% |
| 2014 | 16.53 Million INR | 90.58% |
| 2013 | 8.67 Million INR | 18.76% |
| 2012 | 7.3 Million INR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -60.89 Million INR | -10545.28% |
| 2023 Q4 | 583 Thousand INR | 257.67% |
| 2023 Q3 | 163 Thousand INR | -44.93% |
| 2023 FY | 1.39 Million INR | 176.4% |
| 2023 Q1 | 349 Thousand INR | -69.25% |
| 2023 Q2 | 296 Thousand INR | -15.19% |
| 2022 FY | -1.82 Million INR | -115.93% |
| 2022 Q1 | -27.54 Million INR | -1050.41% |
| 2022 Q2 | 9.38 Million INR | 134.08% |
| 2022 Q3 | 15.2 Million INR | 61.95% |
| 2022 Q4 | 1.13 Million INR | -92.53% |
| 2021 Q3 | 649 Thousand INR | 104.83% |
| 2021 Q1 | 21.32 Million INR | -3.13% |
| 2021 FY | 11.43 Million INR | -91.66% |
| 2021 Q2 | -13.44 Million INR | -163.01% |
| 2021 Q4 | 2.89 Million INR | 346.53% |
| 2020 Q4 | 22.01 Million INR | -45.7% |
| 2020 FY | 137.15 Million INR | 25.86% |
| 2020 Q3 | 40.55 Million INR | 4.55% |
| 2020 Q2 | 38.78 Million INR | 8.38% |
| 2020 Q1 | 35.79 Million INR | -9.63% |
| 2019 FY | 108.96 Million INR | 45.12% |
| 2019 Q2 | 18.88 Million INR | -41.73% |
| 2019 Q1 | 32.41 Million INR | 243.11% |
| 2019 Q3 | 18.06 Million INR | -4.37% |
| 2019 Q4 | 39.6 Million INR | 119.27% |
| 2018 Q3 | 34.79 Million INR | 53.56% |
| 2018 Q2 | 22.65 Million INR | 176.56% |
| 2018 Q1 | 8.19 Million INR | 267.78% |
| 2018 Q4 | 9.44 Million INR | -72.85% |
| 2018 FY | 75.08 Million INR | 338.09% |
| 2017 Q1 | 4.86 Million INR | 268.25% |
| 2017 Q4 | -4.88 Million INR | -149.14% |
| 2017 FY | 17.13 Million INR | 26.78% |
| 2017 Q3 | 9.93 Million INR | 37.58% |
| 2017 Q2 | 7.22 Million INR | 48.48% |
| 2016 Q4 | -2.89 Million INR | -128.25% |
| 2016 FY | 13.51 Million INR | 649.09% |
| 2016 Q1 | 1.83 Million INR | -80.88% |
| 2016 Q2 | 4.34 Million INR | 137.19% |
| 2016 Q3 | 10.23 Million INR | 135.67% |
| 2015 Q1 | 4.14 Million INR | -31.25% |
| 2015 Q3 | -1.28 Million INR | 94.1% |
| 2015 Q2 | -21.71 Million INR | -623.73% |
| 2015 Q4 | 9.57 Million INR | 847.68% |
| 2015 FY | 1.8 Million INR | -89.08% |
| 2014 Q4 | 6.03 Million INR | 38.96% |
| 2014 Q3 | 4.34 Million INR | 39.05% |
| 2014 FY | 16.53 Million INR | 90.58% |
| 2014 Q2 | 3.12 Million INR | 0.0% |
| 2013 Q4 | -3.03 Million INR | -176.47% |
| 2013 Q1 | 3.61 Million INR | 187.53% |
| 2013 Q3 | 3.97 Million INR | -3.66% |
| 2013 FY | 8.67 Million INR | 18.76% |
| 2013 Q2 | 4.12 Million INR | 14.11% |
| 2012 FY | 7.3 Million INR | 0.0% |
| 2012 Q4 | -4.12 Million INR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 15.3 Million INR | 90.904% |
| Checkpoint Trends Limited | 302.09 Thousand INR | -360.79% |
| GUJARAT INJECT (KERALA) LTD. | 827.62 Thousand INR | -68.191% |
| NATURO INDIABULL LIMITED | 9.93 Million INR | 85.983% |
| NEXUS SURGICAL AND MEDICARE LI | 2.13 Million INR | 34.742% |
| Rajnish Wellness Limited | 10.33 Million INR | 86.527% |
| Rama Vision Limited | 33.85 Million INR | 95.889% |
| Vivo Bio Tech Limited | 25.26 Million INR | 94.49% |